Clinician operating laboratory equipment - Invitae Generation genetic variant classificationClinician operating laboratory equipment - Invitae Generation genetic variant classification

Invitae GenerationTM

An evolution of technology—powered by people

Get more precise results through our rigorous, evolving approach to clinical genetic testing.

Over 5 million patients tested and counting - Invitae Generation genetic variant interpretation

We’ve tested over 5 million patients and counting

It’s about patients, not technology

Our data is massive in scale and clinically diverse, enabling ethical data sharing and research crucial for patient access to genetic information.

  • More than 2 million classified unique gene variants

    classified unique gene variants

  • More than 1.7 million submitted variants to ClinVar

    submitted variants to ClinVar

  • More than 200 contributed research articles

    contributed research articles

Icon of a dimensional gauge - Genetic variant classification with integrity

Genetic variant classification with integrity

It takes a lot of expertise and rigor to classify a variant correctly. When we reach definitive genetic classifications, we do so confidently, with over 99% of ours remaining stable.1

A medical professional consulting with a patient - Invitae Generation

It’s not just automated

Invitae Generation automates the parts of variant classification prone to human error. The rest is up to our scientific experts, who tirelessly innovate to do what’s right for patients.

Take a deeper dive

The future of healthcare depends on what we know now and what we can discover.

  • Clinician educational webinars - Invitae icon

    Variant classification webinar

    Examine over 8 years of variant reclassification data, including rates of reversal and root causes.

    Watch recording

  • Provider resource- Invitae icon

    Latest whitepaper

    The most recent update to Invitae Generation: Clinical Variant Modeling helps reclassify VUS.

    View now

  • Papers and presentation - Invitae icon

    ASHG presentation

    View our genetic variant reclassification data presented at ASHG. Full manuscript coming soon.

    View now

Since 2020, we’ve seen a 40% reduction in rates of variants of uncertain significance (VUS) with Invitae Generation technology.1

Get the answers you need, when you need them

No matter your practice’s workflow, we’re with you in the here and now.

Shaping the future of genetic testing—with you

References

1. Invitae internal data on file (2023). Note: Definitive classifications are defined as pathogenic, likely pathogenic, likely benign, and benign.
2. Truty R, et al. Genet Med. 2019;21:114–123.

AltStyle によって変換されたページ (->オリジナル) /